Data from more than 20 well-executed case-control or cohort studies have demonstrated that cigarette smoking is a very significant risk factor (two-to sixfold increase in risk among current smokers) for subarachnoid hemorrhage (SAH), and that the risk increases in a dose-dependent manner. 3,[10][11][12] The association between smoking and SAH is stronger than that between smoking and any other cerebrovascular disease. Furthermore, persons who smoke more than 20 cigarettes per day have an increased risk. In fact, no controlled study has shown a nonsignificant association between smoking and the risk for SAH.
Few researchers have focused on the influence of cigarette smoking on either outcome or survival after SAH. 1, 5, 8, 9 The effect of smoking on the occurrence and severity of delayed symptomatic cerebral ischemia after SAH has been investigated by some researchers. 1, 2, 4, 7, 12 In prospective follow-up studies, 1, 5, 8, 9 cigarette smoking did not significantly affect outcome after SAH. In a populationbased study conducted by Longstreth, et al., 8 a current smoking status before SAH had no significant independent effect on 30-day survival (WT Longstreth, personal communication, 2001) . Similarly, nonsignificant associations between smoking status and death or poor outcome were demonstrated in two hospital-based studies. 1, 9 In a Helsinki study, 1,4 29% of 291 patients with a verified aneurysmal SAH died after bleeding; in most cases death was caused by either the initial hemorrhage or early rebleeding during or soon after transportation. It was very unlikely that the smoking statuses of patients who died before admission to an emergency department would have been different from those of the patients who were admitted. Neither a current smoking status nor the number of cigarettes smoked per day before SAH affected patient outcome, mortality, or the occurrence of early rebleeding. On the other hand, the mean cell volume of erythrocytes was directly associated with poor outcome. This mean cell volume is increased by both cigarette smoking and alcohol consumption. It was heavy alcohol consumption, not smoking, that impaired overall outcome after SAH.
1 Furthermore, our recent prospective follow-up study showed a significant association between the rupture of a previously unruptured aneurysm and cigarette smoking, but smoking did not affect mortality after the aneurysm had ruptured (45% compared with 43%).
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On the other hand, in a large metaanalysis, cigarette smoking before SAH was shown to increase somewhat the risk for symptomatic vasospasm.
12 There was also a trend for smoking (particularly heavy smoking before SAH) to increase the occurrence of delayed ischemia after aneurysmal SAH in our hospital-based study, 1,4 but in two other studies with smaller patient populations a significant association was demonstrated between current smoking status and symptomatic vasospasm, probably due in part to chance. 2, 7 In addition, smoking a cigarette after SAH during the vasospasm phase can cause extensive, acute brain infarction in patients who previously had good-grade SAH. 4, 7 Although cigarette smoking seems to be associated with delayed symptomatic vasospasm, no clear association could be shown between smoking before SAH and angiographic evidence of vasospasm in large cerebral arteries during the second week after SAH.
2 Thus, smoking before SAH may depend on mechanisms of action other than large-artery vasospasm to increase risk for infarction and symptomatic vasospasm after SAH.
New studies of the effect of preictal factors on outcome after SAH are needed to improve and understand recovery from this serious disease. Pobereskin publishes a report of See the corresponding article in this issue, pp 555-559. such a study in an exceptionally large patient population (800 patients with SAH, who had 520 verified cases of aneurysm during a 5-year period) in this issue of the Journal of Neurosurgery. In the paper entitled "Influence of premorbid factors on survival following subarachnoid hemorrhage," he found that patient age older than 60 years, cigarette smoking, and, marginally, female sex were associated with death after SAH. The mean mortality rate among smokers was approximately one half that of nonsmokers, even after adjustment for age and sex. This adjustment was essential because logistic regression tests, which were conducted in a blinded manner, indicated merely an association between variables and not any causal relationship. Without adjustment for confounding factors, one could erroneously conclude that young men recover better after SAH than others because they have smoked. Thus, in the series conducted by Pobereskin, age and sex did not explain this exceptionally strong association between smoking and improved survival after SAH.
In the medical community, there is a general misconception that in collecting data in a large patient population, researchers need not take as much care with their study design. This can cause fundamental systematic errors in the design and performance of a study, which may easily lead to unexpected correlations that are not biologically plausible. Systematic errors that lead to biases cannot be corrected with any kind of statistical method that can be used only for the control of errors caused by chance. Therefore, large studies must be performed as carefully as small ones.
Because the results of Pobereskin's retrospective study are in obvious conflict with those of previous prospective studies, one must use caution when interpreting the kind of protective effect cigarette smoking has on mortality after SAH. This may nullify the beneficial medical health education advanced in several previous epidemiological studies. After findings of this study are disseminated, cigarette companies will likely insist that cigarette smoking may not exacerbate SAH because, although smokers may have an increased risk for SAH, they have, correspondingly, a lower incidence of mortality. Thus, death due to SAH will not be much changed by smoking habits.
There are some sources of serious systematic bias in Pobereskin's study. The most serious potential bias involved the coding of smoking. The author did not personally interview patients or their relatives, but instead relied on different nurses' interviews of patients on admission to various hospitals. As part of their workload, tens or likely hundreds of nurses in various busy emergency rooms, neurosurgical clinics, and so forth, coded patients' smoking statuses by using standard questionnaires or admission checklists (smoking: yes/no), without additional information about duration, amount, or cessation of smoking, and so forth, making coding unreliable. The patients' statuses for premorbid smoking and hypertension were extracted from these medical records without validation of the data.
Data obtained in primary care centers or emergency departments in patients who are dying or who have poor clinical grades cannot be very reliable due to the nature of the work performed by personnel while trying to save the patient's life. At the very least, data obtained in emergency departments of separate hospitals in patients with poor-grade SAH cannot be as reliable as those obtained by nurses in the neurosurgical clinic in patients with goodgrade SAH who are being prepared for surgery. It was also surprising that the proportion of missing data on cigarette smoking in this retrospective study was exceptionally low (1%), compared with previous retrospective or prospective studies. Possibly, some busy nurses may have guessed the patient's smoking status while filling out the checklist.
To avoid this kind of fundamental bias, the researcher or his assistants should have interviewed patients and/ or relatives to confirm smoking status by using a structured questionnaire. The reliability of the study would have been significantly increased, with a relatively short increase in time spent on the additional work. In my experience, family members willingly provide this information, even after the death of the patient, if they believe they can help future sufferers of SAH. A comparison of the rate of smoking in this study with those in other studies of SAH is not convincing. In fact, it seems quite probable that the effects of cigarette smoking in patients with a poor initial condition or in those who died was underestimated.
In addition, cerebral aneurysms were found in only two thirds (65%) of all cases of SAH, reflecting a relatively conservative diagnostic and therapeutic policy toward ruptured intracranial aneurysms. This is supported by the fact that only three consultant neurosurgeons were responsible for treating ruptured aneurysm cases in a catchment area of 1.5 million inhabitants. During the same time period, in most Western neurosurgical centers, more than half of all patients with SAH underwent surgery a median of 1 to 2 days after bleeding. In more than 200 patients who died of bleeding, the diagnosis was based only on the computerized tomography (CT) scan; there had been no verification of the aneurysm by autopsy or angiographic studies. It is well known that patients harboring an aneurysmal SAH and an expansive intracerebral hematoma (ICH) have a significantly higher risk of death than other patients with an aneurysmal SAH. Several patients with fatal ICH may, in reality, have experienced spontaneous hemorrhage in the basal ganglia or other sites; a large spontaneous ICH is difficult to distinguish from aneurysmal bleeding with an expansive hematoma without using angiography or autopsy, and spontaneous ICH is much more common than SAH. Avoiding this kind of misdiagnosis is important because patients with spontaneous ICH are significantly older and have a significantly lower incidence of smoking than patients with SAH.
3 This kind of error may have led in part to the finding of a protective effect of smoking against death from SAH.
Previously, diagnoses obtained from hospital discharge registers or other official registers have been shown to be unreliable because these are filled out by persons with various levels of expertise. Patients with SAH, spontaneous ICH, or other stroke subtypes have quite often been assigned erroneous codes. The CT scans should have been reexamined by an expert on cerebrovascular diseases to reduce the possibility of a misdiagnosis in cases in which there was no aneurysm verification. This was not done in the present series because the films were destroyed before the study. An analysis of mortality risk factors therefore should also have been performed separately for patients with verified aneurysms.
Pobereskin indicates that increased vasospasm in smokers may reduce the severity of the initial hemorrhage. No
